|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2007;84:24
© 2007 The Society of Thoracic Surgeons
Deutsches Herzzentrum Berlin, Department of Cardiothoracic and Vascular Surgery, Augustenburger Platz 1, Berlin, D-13353 Germany
(Email: knosalla@dhzb.de).
| The first 20% of the full text of this article appears below. |
Significant recent advances have been made in strategies for managing ST-segment elevation myocardial infarction (STEMI); randomized controlled trials have guided the introduction of increasingly advanced reperfusion, revascularization, and secondary prevention strategies with resulting improvements in mortality.
Although the surgical management of patients with acute myocardial infarction has been clearly superseded by medical therapy, including percutaneous coronary intervention (PCI), a significant number of patients still require surgical intervention. Thielmann and colleagues [1] report meaningful data regarding
Related Article
Ann. Thorac. Surg. 2007 84: 17-24.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |